Fervent Synergies Ltd
₹ 17.3
10.52%
22 Nov
- close price
About
Incorporated in 2012, Fervent Synergies Ltd is in the business of food and finance
Key Points
- Market Cap ₹ 52.0 Cr.
- Current Price ₹ 17.3
- High / Low ₹ 27.8 / 14.6
- Stock P/E
- Book Value ₹ 11.8
- Dividend Yield 0.00 %
- ROCE -34.8 %
- ROE -34.9 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -10.4% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | 3 | 4 | 4 | 39 | 6 | 17 | 7 | 2 | 1 | 5 | 24 | 24 | |
0 | 0 | 1 | 1 | 36 | 4 | 15 | 7 | 2 | 1 | 4 | 37 | 37 | |
Operating Profit | 2 | 2 | 3 | 3 | 3 | 1 | 1 | 0 | 0 | -0 | 0 | -13 | -13 |
OPM % | 81% | 81% | 85% | 82% | 7% | 20% | 8% | 6% | 13% | -26% | 10% | -53% | -53% |
-1 | -0 | 0 | -0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit before tax | 1 | 2 | 3 | 3 | 3 | 1 | 2 | 0 | 0 | -0 | 0 | -13 | -13 |
Tax % | 32% | 33% | 33% | 34% | 27% | 27% | 29% | 26% | 26% | 20% | 48% | 0% | |
1 | 1 | 2 | 2 | 2 | 1 | 1 | 0 | 0 | -0 | 0 | -13 | -13 | |
EPS in Rs | 0.23 | 0.53 | 0.65 | 0.64 | 0.80 | 0.28 | 0.41 | 0.08 | 0.06 | -0.08 | 0.08 | -4.28 | -4.32 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 25% |
5 Years: | 8% |
3 Years: | 122% |
TTM: | 409% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -4018% |
Stock Price CAGR | |
---|---|
10 Years: | -10% |
5 Years: | 4% |
3 Years: | 10% |
1 Year: | -5% |
Return on Equity | |
---|---|
10 Years: | -1% |
5 Years: | -6% |
3 Years: | -10% |
Last Year: | -35% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 25 | 25 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 |
Reserves | 2 | 3 | 6 | 8 | 11 | 12 | 13 | 13 | 13 | 13 | 13 | 0 | 5 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | |
Total Liabilities | 27 | 29 | 37 | 39 | 42 | 42 | 43 | 43 | 44 | 43 | 43 | 31 | 36 |
0 | 0 | 0 | 0 | 2 | 4 | 18 | 18 | 18 | 16 | 16 | 8 | 8 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 1 | 1 | 0 | 2 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
26 | 28 | 37 | 37 | 40 | 38 | 25 | 25 | 25 | 27 | 27 | 23 | 28 | |
Total Assets | 27 | 29 | 37 | 39 | 42 | 42 | 43 | 43 | 44 | 43 | 43 | 31 | 36 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3 | -4 | 1 | -6 | -2 | 3 | 12 | 2 | 0 | -2 | -0 | -0 | |
0 | 0 | 1 | -2 | 1 | -2 | -14 | -0 | 0 | 2 | 0 | 0 | |
0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Net Cash Flow | 3 | -4 | 8 | -8 | -1 | 0 | -2 | 2 | 0 | 0 | -0 | -0 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0 | 0 | 0 | 0 | 43 | 46 | 66 | 132 | 289 | 0 | 47 | 0 |
Inventory Days | 12 | 0 | 0 | 81 | 0 | 0 | 0 | |||||
Days Payable | 0 | 0 | ||||||||||
Cash Conversion Cycle | 0 | 0 | 0 | 0 | 55 | 46 | 66 | 212 | 289 | 0 | 47 | 0 |
Working Capital Days | 1,395 | 1,993 | 1,590 | 2,337 | 256 | 1,437 | 249 | 482 | 3,260 | 14,332 | 2,132 | 345 |
ROCE % | 7% | 7% | 9% | 8% | 8% | 3% | 4% | 1% | 1% | -0% | 1% | -35% |
Documents
Announcements
-
Financial Results For The Quarter And Half Year Ended 30Th Sep 2024
24 Oct - Approved Q2 financial results and name change application.
-
Board Meeting Intimation for Unaudited Results For The Quarter Ended 30Th Sep 2024
17 Oct - Board meeting scheduled for financial results approval.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 12 Oct
-
Closure of Trading Window
26 Sep - Closure of trading window from October 1, 2024.
- Unaudited Results For The Quarter Ended 30Th June 2024 8 Aug
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
Company used to deal in Pharmaceutical and Chemical products, import-export trading and distribution of various chemicals solvents API intermediates & other bulk drugs